These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19422419)

  • 1. DRAGON, a GPI-anchored membrane protein, inhibits BMP signaling in C2C12 myoblasts.
    Kanomata K; Kokabu S; Nojima J; Fukuda T; Katagiri T
    Genes Cells; 2009 Jun; 14(6):695-702. PubMed ID: 19422419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
    Gutierrez J; Osses N; Brandan E
    J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells.
    Tanaka K; Inoue Y; Hendy GN; Canaff L; Katagiri T; Kitazawa R; Komori T; Sugimoto T; Seino S; Kaji H
    Bone; 2012 Jul; 51(1):158-67. PubMed ID: 22579779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling.
    Mukai T; Otsuka F; Otani H; Yamashita M; Takasugi K; Inagaki K; Yamamura M; Makino H
    Biochem Biophys Res Commun; 2007 May; 356(4):1004-10. PubMed ID: 17397798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of the Ski-interacting protein (SKIP) on differentiation induced by transforming growth factor-beta1 and bone morphogenetic protein-2 in C2C12 cells.
    Figueroa JD; Hayman MJ
    Exp Cell Res; 2004 Jun; 296(2):163-72. PubMed ID: 15149847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
    Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
    J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
    Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
    Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
    Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
    J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community effect triggers terminal differentiation of myogenic cells derived from muscle satellite cells by quenching Smad signaling.
    Yanagisawa M; Mukai A; Shiomi K; Song SY; Hashimoto N
    Exp Cell Res; 2011 Jan; 317(2):221-33. PubMed ID: 20965167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts.
    Nakashima A; Katagiri T; Tamura M
    J Biol Chem; 2005 Nov; 280(45):37660-8. PubMed ID: 16150699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DRAGON, a bone morphogenetic protein co-receptor.
    Samad TA; Rebbapragada A; Bell E; Zhang Y; Sidis Y; Jeong SJ; Campagna JA; Perusini S; Fabrizio DA; Schneyer AL; Lin HY; Brivanlou AH; Attisano L; Woolf CJ
    J Biol Chem; 2005 Apr; 280(14):14122-9. PubMed ID: 15671031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-rich plasma stimulates osteoblastic differentiation in the presence of BMPs.
    Tomoyasu A; Higashio K; Kanomata K; Goto M; Kodaira K; Serizawa H; Suda T; Nakamura A; Nojima J; Fukuda T; Katagiri T
    Biochem Biophys Res Commun; 2007 Sep; 361(1):62-7. PubMed ID: 17632078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation.
    Nakagawa K; Imai Y; Ohta Y; Takaoka K
    Bone; 2007 Oct; 41(4):543-8. PubMed ID: 17681894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix.
    Behnam K; Murray SS; Brochmann EJ
    Connect Tissue Res; 2006; 47(5):271-7. PubMed ID: 17118749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta1 and bone morphogenetic protein-2 downregulate CaV3.1 channel expression in mouse C2C12 myoblasts.
    Avila T; Andrade A; Felix R
    J Cell Physiol; 2006 Nov; 209(2):448-56. PubMed ID: 16883604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signals that determine the fate of osteoblastic cells.
    Canalis E; Deregowski V; Pereira RC; Gazzerro E
    J Endocrinol Invest; 2005; 28(8 Suppl):3-7. PubMed ID: 16329200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canonical Wnts and BMPs cooperatively induce osteoblastic differentiation through a GSK3beta-dependent and beta-catenin-independent mechanism.
    Fukuda T; Kokabu S; Ohte S; Sasanuma H; Kanomata K; Yoneyama K; Kato H; Akita M; Oda H; Katagiri T
    Differentiation; 2010 Jul; 80(1):46-52. PubMed ID: 20546990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurogenesin-1 differentially inhibits the osteoblastic differentiation by bone morphogenetic proteins in C2C12 cells.
    Chandra A; Itakura T; Yang Z; Tamakoshi T; Xue X; Wang B; Ueki T; Sato K; Uezato T; Miura N
    Biochem Biophys Res Commun; 2006 Jun; 344(3):786-91. PubMed ID: 16630536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4.
    Xia Y; Yu PB; Sidis Y; Beppu H; Bloch KD; Schneyer AL; Lin HY
    J Biol Chem; 2007 Jun; 282(25):18129-18140. PubMed ID: 17472960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.